Literature DB >> 17304823

No overt cellular inflammation around intravascular schistosomes in vivo.

John H Keating1, R Alan Wilson, Patrick J Skelly.   

Abstract

Schistosomes are intravascular platyhelminth parasites that are exposed in the blood stream to host immunological effectors. Antibody-dependent cell-mediated cytotoxicity (ADCC) can act in vitro to kill the parasites, and this has been proposed as one important mechanism of antiworm immunity in vivo. In this study, we examined sections of adult Schistosoma mansoni in situ, within the vasculature of strains of mice that exhibit low (Balb/c) or high (CBA) pathology, and in the vasculature of infected chimpanzees, for evidence of cellular inflammation around the worms. In both mouse strains, we observe robust cellular inflammation around the parasite eggs in the intestines and liver tissue. However, we detect no overt cellular inflammation around the mature parasites in vivo. Likewise in the vasculature of infected chimpanzees, no immune cell accumulations are detected around adult schistosomes in situ. These data suggest that the parasites can promote a polar immune response that targets eggs (and assists the eggs to exit the host and continue the life cycle) but that does not effectively target the source of those eggs, namely, the adult worms.

Entities:  

Mesh:

Year:  2006        PMID: 17304823     DOI: 10.1645/GE-864R.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  28 in total

1.  Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Afzal A Siddiqui
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Schistosomes can hydrolyze proinflammatory and prothrombotic polyphosphate (polyP) via tegumental alkaline phosphatase, SmAP.

Authors:  Manal Elzoheiry; Akram A Da'dara; Catherine S Nation; Samar N El-Beshbishi; Patrick J Skelly
Journal:  Mol Biochem Parasitol       Date:  2019-05-30       Impact factor: 1.759

3.  [Radiculomyelopathy in schistosomiasis].

Authors:  J Detzler; H Backes; J Guldner
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

4.  How schistosomes alter the human serum proteome.

Authors:  Akram A Da'dara; Giles Siddons; Melissa Icaza; Qiang Wang; Patrick J Skelly
Journal:  Mol Biochem Parasitol       Date:  2016-12-21       Impact factor: 1.759

5.  Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.

Authors:  Jorge Sepulveda; Jacqueline M Tremblay; Jon P DeGnore; Patrick J Skelly; Charles B Shoemaker
Journal:  Int J Parasitol       Date:  2010-06-30       Impact factor: 3.981

6.  The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis as determined by thromboelastography (TEG).

Authors:  Akram A Da'dara; Armelle M de Laforcade; Patrick J Skelly
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

Review 7.  Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.

Authors:  R Alan Wilson; Patricia S Coulson
Journal:  Trends Parasitol       Date:  2009-08-28

Review 8.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

Review 9.  Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.

Authors:  Chiuan Yee Leow; Charlene Willis; Andreas Hofmann; Malcolm K Jones
Journal:  Br J Pharmacol       Date:  2014-12-23       Impact factor: 8.739

10.  Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Stewart Nash; Loc Le; Souvik Karmakar; Afzal A Siddiqui
Journal:  Vaccine       Date:  2012-09-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.